PATENT CLAIM ANALYSIS

Application Number: 15752839
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["546", "193000"]

Abstract:
The invention generally relates to cyclic compounds and, more particularly, to a compound represented by Structural Formula I: or a pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the multicyclic compounds. The invention also relates to a method for treating a disease or disorder selected from cancer (e.g., lymphoma, such as mantle cell lymphoma), a neurodegenerative disease, an inflammatory diseases or an immune system disease (e.g., a T-Cell mediated autoimmune disease) in a subject in need thereof. The method comprises administering to a subject in need thereof a therapeutically effective amount of a compound of the invention, or a pharmaceutically acceptable salt thereof, or a composition comprising a compound of the invention, or a pharmaceutically acceptable salt thereof.

Claim (Index 34):
The compound of  claim 32 , wherein X 1  is \u2014O\u2014 and X 2  is \u2014N\u2014.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 2.06061
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14902202', '15831111', '15023269', '14647662', '15482581']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.768338406704429
- 35 USC 102 Novelty (BERT): 0.5345126219523963
- Combined Prediction Score: 0.7449558282292258
- Mean Citation Score: 299.7375600000001
- Max Citation Score: 343.36664
- Similarity Product: 204.13550113161088

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test